Vitti R A, Meyers F, Knight L C, Siegel J A, Malmud L S, Fisher R S
Department of Diagnostic Imaging, Temple University Hospital, Philadelphia, Pennsylvania.
Dig Dis Sci. 1989 Nov;34(11):1792-7. doi: 10.1007/BF01540060.
Rectally administered suspensions of 5-aminosalicylic acid (5-ASA) are topically effective in treating left-sided ulcerative colitis. The extent to which the contents of these enemas are distributed to inflamed mucosal linings has not previously been determined. This study was undertaken to validate a technique for labeling 5-ASA with 99mTc and to quantitate the distribution of [99mTc]5-ASA in eight patients with left-sided ulcerative colitis. Eight patients underwent three colonic scintigraphic exams within five days, receiving a 60-ml radiolabeled 5-ASA enema into the unprepared rectum for each study, with sequential anterior abdominal images obtained for 4 hr. Activity within the rectum, sigmoid, descending, transverse, and ascending colon was quantitated. Over 50% of the labeled enema had advanced beyond the rectum in five of eight patients and in six of eight patients by 30 min and 60 min, respectively. The distribution of [99mTc]5-ASA was quantitatively reproducible when repeated in the same patient on different days, despite apparent visual differences. By 2 hr, the amount of the enema present within the rectum decreased significantly (P less than 0.05) compared to the initial distribution. The amount of enema present within the descending colon was increased significantly at 0.5 hr (P less than 0.05) and at 2 hr (P less than 0.01). There were no significant changes in the distribution from initial values for the sigmoid, transverse, or ascending colon at any time. In each of these cases the spread of the enema to or beyond the extent of disease was documented. In patients with left-sided ulcerative colitis, small volume [99mTc]5-ASA enemas reliably reach the area of inflammation.
经直肠给药的5-氨基水杨酸(5-ASA)混悬液在治疗左侧溃疡性结肠炎方面具有局部疗效。此前尚未确定这些灌肠剂的内容物在炎症性黏膜内衬中的分布程度。本研究旨在验证一种用99mTc标记5-ASA的技术,并对8例左侧溃疡性结肠炎患者中[99mTc]5-ASA的分布进行定量分析。8例患者在5天内接受了3次结肠闪烁扫描检查,每次研究均将60 ml放射性标记的5-ASA灌肠剂注入未做准备的直肠,并连续采集4小时的腹部前位图像。对直肠、乙状结肠、降结肠、横结肠和升结肠内的活性进行定量分析。8例患者中有5例在30分钟时、6例在60分钟时,超过50%的标记灌肠剂已推进至直肠以外。尽管在视觉上存在明显差异,但在同一天对同一患者重复进行[99mTc]5-ASA分布的定量分析时,结果具有可重复性。到2小时时,与初始分布相比,直肠内的灌肠剂含量显著减少(P<0.05)。降结肠内的灌肠剂含量在0.5小时(P<0.05)和2小时(P<0.01)时显著增加。乙状结肠、横结肠或升结肠在任何时候的分布与初始值相比均无显著变化。在每例患者中,均记录了灌肠剂扩散至病变范围或超出病变范围的情况。对于左侧溃疡性结肠炎患者,小剂量的[99mTc]5-ASA灌肠剂能够可靠地到达炎症区域。